Diagnostic performance of bone scintigraphy and 11C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer

被引:15
|
作者
Garcia, J. R. [1 ]
Moreno, C. [1 ]
Valls, E. [1 ]
Cozar, P. [1 ]
Bassa, P. [1 ]
Soler, M. [1 ]
Alvarez-Moro, F. J. [1 ]
Moragas, M. [1 ]
Riera, E. [1 ]
机构
[1] Unidad PET CETIR ERESA, Barcelona, Spain
来源
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR | 2015年 / 34卷 / 03期
关键词
Bone scintigraphy; C-11-Choline PET/CT; Bone metastases; Biochemical recurrence; Prostate cancer; POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; F-18-FLUORIDE PET; F-18-FDG PET/CT; DISEASE; SPECT; ONCOLOGY; RELAPSE; CT;
D O I
10.1016/j.remn.2014.08.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim: To compare bone scan (BS) with C-11-Choline PET/CT for the detection of bone metastases in patients with biochemical recurrence of prostate cancer (PC). Material and Methods: A total of 169 patients with biochemical recurrence of PC(PSA:2.4-58 ng/ml) who were referred for both exams (0-15 days-in-between) were included. Lesion-detection-rate per patients and lesions were analyzed for both BS and C-11-Choline PET/CT. Metastasis diagnosis was reached by: biopsy, CT/F-18-Fluoride PET/MRI confirmation, or evidence of progression in subsequent imaging procedures. Results: A total of 91 lesions were found to be active in BS and/or C-11-choline PET/CT (40 patients), with 78 of which were metastatic. BS detected 38 blastic, 2 lytic and 10 non-CT-evident lesions. C-11-Choline PET/CT detected 41 blastic, 4 lytic and 29 non-CT-evident lesions. BS and C-11-Choline PET/CT sensitivities were 65.4% and 96.1%; specificities ere 38.5 and 92.3% (chi(2) 8.27, p < 0.04). Both imaging techniques were negative in 118 patients. Tracer avid lesions were found in 51 patients: with 30/51 being BS and C-11-Choline PET/CT concordant; in 21/51 patients had discordant lesions (kappa 0.712, p = 0.00). Lesions were absolutely discordant in 10/19 patients,: 5 FN BS, 2 FP BS (degenerative changes: dysplasia), 1 FN C-11-Choline PET/CT (blastic), 1 FP C-11-Choline PET/CT (degenerative), 1 out of field-of-view lesion with C-11-Choline PET/CT (tibia alone). C-11-Choline PET/CT showed extraosseous involvement in 26/51 patients with bone metastases: 9 local recurrences, 5 infra-diaphragmatic-lymph-nodes, 2 supra-diaphragmatic, 5 local and infra-diaphragmatic, 4 infra- and supra-diaphragmatic, 1 supra-diaphragmatic and lung metastases. Conclusion: C-11-Choline PET/CT yielded better sensitivity and specificity than BS for the detection of bone involvement in patients with biochemical recurrence of PC and allowed extraosseous restaging, with an impact in the clinical management of these patients. (C) 2014 Elsevier Espana, S.L.U. and SEMNIM. All rights reserved.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 50 条
  • [1] Diagnostic performance of 11C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer
    Kitajima, Kazuhiro
    Fukushima, Kazuhito
    Yamamoto, Shingo
    Kato, Takashi
    Odawara, Soichi
    Takaki, Haruyuki
    Fujiwara, Masayuki
    Yamakado, Koichiro
    Nakanishi, Yukako
    Kanematsu, Akihiro
    Nojima, Michio
    Hirota, Shozo
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2017, 79 (03): : 387 - 399
  • [2] Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy
    Fuccio, Chiara
    Castellucci, Paolo
    Schiavina, Riccardo
    Santi, Ivan
    Allegri, Vincenzo
    Pettinato, Vincenzina
    Boschi, Stefano
    Martorana, Giuseppe
    Al-Nahhas, Adil
    Rubello, Domenico
    Fanti, Stefano
    ANNALS OF NUCLEAR MEDICINE, 2010, 24 (06) : 485 - 492
  • [3] [11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy
    Picchio, Maria
    Spinapolice, Elena Giulia
    Fallanca, Federico
    Crivellaro, Cinzia
    Giovacchini, Giampiero
    Gianolli, Luigi
    Messa, Cristina
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (01) : 13 - 26
  • [4] Bone Metastases from Prostate Cancer 18F-Fluoride PET/CT in a Patient With Discordant Bone Scintigraphy and 11C-Choline PET/CT
    Garcia, Garzon, Jr.
    Riera, Eduard
    Valls, Eulalia
    Soler, Marina
    Bassa, Pere
    Moragas, Merce
    Lomena, Francisco
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (02) : 120 - 124
  • [5] Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis
    Shen, Guohua
    Deng, Houfu
    Hu, Shuang
    Jia, Zhiyun
    SKELETAL RADIOLOGY, 2014, 43 (11) : 1503 - 1513
  • [6] A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer
    Wondergem, Maurits
    van der Zant, Friso M.
    van der Ploeg, Tjeerd
    Knol, Remco J. J.
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (10) : 935 - 945
  • [7] Detection of Bone Metastases Using 11C-Acetate PET in Patients with Prostate Cancer with Biochemical Recurrence
    Spick, Claudio
    Polanec, Stephan H.
    Mitterhauser, Markus
    Wadsak, Wolfgang
    Anner, Philip
    Reiterits, Bettina
    Haug, Alexander R.
    Hacker, Marcus
    Beheshti, Mohsen
    Karanikas, Georgios
    ANTICANCER RESEARCH, 2015, 35 (12) : 6787 - 6791
  • [8] Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients
    Beheshti, Mohsen
    Langsteger, Werner
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (05) : 910 - 911
  • [9] Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients
    Mohsen Beheshti
    Werner Langsteger
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 910 - 911
  • [10] Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer
    Kitajima, Kazuhiro
    Yamamoto, Shingo
    Odawara, Soichi
    Kobayashi, Kaoru
    Fujiwara, Masayuki
    Kamikonya, Norihiko
    Fukushima, Kazuhito
    Nakanishi, Yukako
    Hashimoto, Takahiko
    Yamada, Yusuke
    Suzuki, Toru
    Kanematsu, Akihiro
    Nojima, Michio
    Yamakado, Koichiro
    ACTA MEDICA OKAYAMA, 2018, 72 (03) : 289 - 296